Pacifica Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Pacifica Partners's BMY Position: Q2 2026 in Review
Pacifica Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 230 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #285.
Pacifica Partners first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.2M in Q2 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Pacifica Partners held 230 shares of Bristol-Myers Squibb worth $13.4K as of Q2 2026.
- Pacifica Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #285 holding.
- Pacifica Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
- Pacifica Partners's Bristol-Myers Squibb position peaked at $4.2M in Q2 2023.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.